DiscoverHeart and Soul of Oncology NavigationA Look Into the CEACAM 5 Biomarker
A Look Into the CEACAM 5 Biomarker

A Look Into the CEACAM 5 Biomarker

Update: 2024-01-25
Share

Description

To close out this 3-part series, Terri Conneran, founder of KRAS (Knowledge + Research + Advocacy = Survivorship) Kickers, Jennifer Aversano, MSN, RN, OCN, ONN-CG, a lung nurse navigator at Northwest Community Hospital, and Claudia Miller, RN, ONC, ONN-CG, a thoracic oncology nurse navigator at Hollings Cancer Center, will explore the CEACAM 5 biomarker, clinical trial recruitment strategies deployed by navigators, and the role that shared decision-making has on patient outcomes throughout their treatment. 

Thank you to our sponsor, Sanofi, for making this biomarker podcast series possible. 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

A Look Into the CEACAM 5 Biomarker

A Look Into the CEACAM 5 Biomarker

The Academy of Oncology Nurse & Patient Navigators